The simple phospholipid, lysophosphatidic acid (LPA) is an autacoid that, like prostaglandins and adenosine, can be generated by many cell types and binds to a family of G-protein coupled receptors (LPA1, LPA2 and LPA3). LPA has heterogeneous functional effects including cellular proliferation, alterations in differentiation, cell survival, suppression of apoptosis and platelet aggregation. In addition to these effects, LPA is similar to other inflammatory lipid mediators (platelet activating factor, prostaglandins, thromboxane) and has the capacity to evoke an immune response by attracting and activating immune cells and regulating leukocyte endothelial cell interaction. These multiple divergent responses are likely mediated by specific LPA receptors that have distinct signaling mechanisms. The high concentration of LPC in plasma and serum suggests that local production of LPA could evoke an injury response that may play a significant role in ischemia-reperfusion injury (IRI). This is supported by our preliminary data that indicate that, VPC12249, a selective LPA1/LPA3 antagonist markedly reduces IR injury >70% in mouse kidneys. The dramatic response by this compound underscores the critical role that LPA receptors play in renal tubule cell survival and injury. Thus we hypothesize that renal ischemia reperfusion induces locally an increase in LPA levels that mediates heterogeneous effects; LPA2 activation mediates cells survival and LPA3 activation mediates tissue injury.
Aim 1 tests the hypothesis that a selective LPA3 antagonism mediates protection from IR.
Aim 2 tests the hypothesis that Nudeotide Pyrophosphatase/Phosphodiesterase (NPP) family regulates renal LPA levels locally during renal IR injury.
Aim 3 tests the hypothesis that LPA3 mediates tissue injury through bone marrow (BM) and non-BM derived ceils.
Aim 4 tests the hypothesis that proximal tubule (PT) LPA3 receptor blockade and LPA2 activation mediates tissue protection. This proposal combines expertise in the LPA synthetic chemistry program of Drs. Timothy Macdonald (Professor, Department of Chemistry, UVA) and Kevin R. Lynch (Professor, Department of Pharmacology, UVA) that will provide incisive molecular and pharmacological reagents in studies that are designed to define the specific effects of LPA receptor subtypes and the mechanisms of protection by selective blockade of LPA receptors. Furthermore, these studies will provide the foundation for future human clinical trials of acute renal failure and renal allograft preservation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK065957-04
Application #
7254740
Study Section
Pathobiology of Kidney Disease Study Section (PBKD)
Program Officer
Maric-Bilkan, Christine
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2009-06-30
Support Year
4
Fiscal Year
2007
Total Cost
$318,115
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Jo, Sang-Kyung; Bajwa, Amandeep; Ye, Hong et al. (2009) Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int 75:167-75
Bajwa, Amandeep; Kinsey, Gilbert R; Okusa, Mark D (2009) Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 10:1196-204
Jo, S-K; Bajwa, A; Awad, A S et al. (2008) Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int 73:1220-30
Kinsey, Gilbert R; Li, Li; Okusa, Mark D (2008) Inflammation in acute kidney injury. Nephron Exp Nephrol 109:e102-7
Okusa, Mark D; Lynch, Kevin R (2007) Targeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury. Drug Discov Today Dis Mech 4:55-59
Rosner, Mitchell H; Okusa, Mark D (2006) Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1:19-32
Day, Yuan-Ji; Huang, Liping; Ye, Hong et al. (2006) Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 176:3108-14
Awad, Alaa S; Ye, Hong; Huang, Liping et al. (2006) Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 290:F1516-24
Li, Li; Okusa, Mark D (2006) Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol 2:432-44